Overall, the modulation of different co-factors in the PI3K/AKT signaling pathway by anthocyanins represents a promising strategy for CRC treatment, leveraging their natural bioactive properties to inhibit cancer cell growth and promote apoptosis through multiple molecular mechanisms. The gene discussed is AKT1; the disease is cancer.